Register
Login:
Share:
Email Facebook Twitter

VAL Share Chat - RSS Feed

Valirx Share Chat (VAL)



Share Price: 0.35Bid: 0.33Ask: 0.37Change: 0.00 (0.00%)No Movement on Valirx
Spread: 0.04Spread as %: 12.12%Open: 0.35High: 0.35Low: 0.35Yesterday’s Close: 0.35



Share Discussion for Valirx (VAL)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Dave1805
Posts: 70
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (6)
RE: Re-rating of share price...
11 Jul '14
My opinion, and also experience with a couple of other biotechs, is that there will be a significant re-rating on announcement of commencement (hard to predict a figure but maybe 50-100% rise). Then on conclusion of successful Ph II, who knows? A further 300%, 400%, 500%..... Then with buyout/partnering interest who knows? Anyone got any thoughts on exit points?
 
Stach
Posts: 4,825
Answer
Opinion:No Opinion
Price:0.33
Multibagger1...
11 Jul '14
Hi and yes it should but it is the dosing and the responses that will do that (or not if we are unlucky).There were examples of pharmaceuticals announcing of starting the clinical trials and that alone has pushed the share prices up ,which subsequently have fallen back where they were or even lower.The good or excellent preliminary reports on the progress of patients almost always pushes significantly North the share price.In our case of VAL201 we should know relatively soon after the start if the patients with prostate cancer respond to it or not.I am not sure about 8 weeks a 12 weeks will be a minimum imo.Stach
Cacher
Posts: 1,763
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (6)
RE: Re-rating of share price...
11 Jul '14
Agreed MB.
Insane suggestion from Stach IMO
Teamhanz
Posts: 259
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (6)
RE: Re-rating of share price...
11 Jul '14
post rec MB.
Multibagger1
Posts: 1,070
Premium Chat Member
Off Topic
Opinion:Strong Buy
Price:0.33
View Thread (6)
RE: Re-rating of share price...
11 Jul '14
Afternoon Stach,
For me there is a big difference between a company in research and development and a company dosing humans in phase II. The SP is sure to reflect this difference.
Cacher
Posts: 1,763
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (6)
RE: Re-rating of share price...
11 Jul '14
Rubbish!
Stach
Posts: 4,825
Observation
Opinion:No Opinion
Price:0.33
View Thread (6)
Re-rating of share price...
11 Jul '14
I really think that MHRA Permit for VAL201 will not make much difference to the share price.What will make a huge difference will be a positive report on the initial progress of the patients that VAL will announce via RNS.It is a waste of time going on about it forever as it has not and will not make a slightest difference on the prices here.Stach
Obelix
Posts: 6,470
Off Topic
Opinion:No Opinion
Price:0.33
Guys
11 Jul '14
The last trade was 13.39?
Cacher
Posts: 1,763
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (2)
RE: Sweepstake
11 Jul '14
Bit of fun whilst we wait...and the proceeds to charity.
Yeah, why not..
The_Bit_Before
Posts: 185
Off Topic
Opinion:Strong Buy
Price:0.33
View Thread (2)
Sweepstake
11 Jul '14
I wonder whether we could find some online sweepstake facility and run one on the timing of the MHRA green light? Obviously, the more enthusiastic amongst our number would be keen to bag this afternoon, Monday and Tuesday, whilst the more conservative and patient would pick dates into the start of August.

All proceeds to a prostate cancer charity (it would seem appropriate given the focus of VAL201).

Who'd be interested? I'm not going to go finding out if it's do-able if there's not interest.



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.